rhabdomyolysis

From Aaushi
Jump to navigation Jump to search

Etiology

Pathology

  • myoglobin released from muscle damages the kidney

Clinical manifestations

Laboratory

Complications

Management

More general terms

More specific terms

Additional terms

References

  1. Manual of Medical Therapeutics, 28th ed, Ewald & McKenzie (eds), Little, Brown & Co, Boston, 1995, pg 265
  2. Mayo Internal Medicine Board Review, 1998-99, Prakash UBS (ed) Lippincott-Raven, Philadelphia, 1998, pg 598
  3. Geriatrics Review Syllabus, American Geriatrics Society, 5th edition, 2002-2004 Epstein M, J Am Soc Nephrol 7:1106, 1996
  4. Warren JD et al, Rhabdomyolysis: a review. Muscle Nerve 2002, 1:427 PMID: https://www.ncbi.nlm.nih.gov/pubmed/11870710
  5. 5.0 5.1 5.2 5.3 5.4 Medical Knowledge Self Assessment Program (MKSAP) 15, 16, 17, 18. American College of Physicians, Philadelphia 2009, 2012, 2015, 2018
  6. 6.0 6.1 6.2 Better OS, Abassi ZA. Early fluid resuscitation in patients with rhabdomyolysis. Nat Rev Nephrol. 2011 May 17;7(7):416-22 PMID: https://www.ncbi.nlm.nih.gov/pubmed/21587227
  7. Bosch X, Poch E, Grau JM. Rhabdomyolysis and acute kidney injury. N Engl J Med. 2009 Jul 2;361(1):62-72 PMID: https://www.ncbi.nlm.nih.gov/pubmed/19571284
  8. Zimmerman JL, Shen MC. Rhabdomyolysis. Chest. 2013 Sep;144(3):1058-65. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/24008958
  9. 9.0 9.1 Asplund CA, O'Connor FG. Challenging Return to Play Decisions: Heat Stroke, Exertional Rhabdomyolysis, and Exertional Collapse Associated With Sickle Cell Trait. Sports Health. 2016 Mar-Apr;8(2):117-25. PMID: https://www.ncbi.nlm.nih.gov/pubmed/26896216
    Saxena P, Chavarria C, Thurlow J. Rhabdomyolysis in a Sickle Cell Trait Positive Active Duty Male Soldier. US Army Med Dep J. 2016 Jan-Mar:20-3. PMID: https://www.ncbi.nlm.nih.gov/pubmed/26874092
  10. Cervellin G, Comelli I, Benatti M et al Non-traumatic rhabdomyolysis: Background, laboratory features, and acute clinical management. Clin Biochem. 2017 Aug;50(12):656-662. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/28235546
  11. Rowan C, Brinker AD, Nourjah P et al Rhabdomyolysis reports show interaction between simvastatin and CYP3A4 inhibitors. Pharmacoepidemiol Drug Saf. 2009 Apr;18(4):301-9. PMID: https://www.ncbi.nlm.nih.gov/pubmed/19206087
  12. Rothaus C. A Woman with Weakness, Dark Urine, and Dysphagia. NEJM Resident 360. July 17, 2019 https://resident360.nejm.org/clinical-pearls/a-woman-with-weakness-dark-urine-and-dysphagia
  13. 13.0 13.1 13.2 13.3 NEJM Knowledge+ Nephrology/Urology
  14. Long B, Koyfman A, Gottlieb M. An evidence-based narrative review of the emergency department evaluation and management of rhabdomyolysis. Am J Emerg Med. 2019;37:518-23. PMID: https://www.ncbi.nlm.nih.gov/pubmed/30630682
  15. 15.0 15.1 Sabouri AH, Yurgionas B, Khorasani S et al Acute Kidney Injury in Hospitalized Patients With Exertional Rhabdomyolysis. JAMA Netw Open. 2024 Aug 1;7(8):e2427464. PMID: https://www.ncbi.nlm.nih.gov/pubmed/39136944 PMCID: PMC11322840 Free PMC article. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2822294
  16. Medline Plus: Rhabdomyolysis http://www.nlm.nih.gov/medlineplus/ency/article/000473.htm